IFNG and melanoma: Firstly, Taniguchi et al. (97) observed that treatment of H-2-deficient non-metastatic B16 melanoma cells with physiological doses of IFN-γ (1–10 U/ml) was sufficient to decrease cell growth in vitro and, surprisingly, to increase the lung-colonizing potential of these cells in vivo.